Get App Open
In App
Credit Cards
Open App
Loans
Loans

ICICI Prudential Nifty Pharma Index Fund - Regular Plan - Growth

  • Regular
  • Direct
Category : Sectoral/Thematic

Returns (NAV as on 05th December, 2025)

Period Invested for ₹10000 Invested on Latest Value Absolute Returns Annualised Returns Category Avg Rank within Category
1 Week 28-Nov-25 9975.80 -0.24% - -0.63% 70/242
1 Month 04-Nov-25 10266.00 2.66% - -0.21% 20/250
3 Month 05-Sep-25 10441.90 4.42% - 2.87% 81/245
6 Month 05-Jun-25 10594.50 5.95% - 4.34% 70/234
YTD 01-Jan-25 9766.00 -2.34% - 4.17% 170/220
1 Year 05-Dec-24 10190.80 1.91% 1.91% 1.19% 81/208
2 Year 05-Dec-23 13989.90 39.90% 18.25% 15.12% 39/163
Since Inception 14-Dec-22 17407.10 74.07% 20.46% 11.89% 20/219

SIP Returns (NAV as on 05th December, 2025)

Period Invested for ₹1000 SIP Started on Investments Latest Value Absolute Returns Annualised Returns
1 Year 05-Dec-24 12000 12644.93 5.37 % 10.09 %
2 Year 05-Dec-23 24000 26513.36 10.47 % 9.88 %

Compare performance

Category 1 D 1 M 3 M 6 M YTD 1 Y 2 Y 3 Y 5 Y
This Fund -0.05% 2.66% 4.42% 5.95% -2.15% 1.91% 18.25% 0.00% 0.00%
Nifty 50 0.59% 2.30% 5.84% 5.80% 10.75% 5.98% 12.04% 11.86% 14.56%
Benchmark: Nifty Pharma TRI -0.05% 2.76% 4.69% 6.54% -1.29% 2.88% 19.70% 21.57% 14.01%
Category Average 0.13% -0.21% 2.87% 4.34% 4.17% 1.19% 15.12% 17.70% 19.27%
Category Rank 136/217 20/250 81/245 70/234 170/220 81/208 39/163 0/0 0/0
Best in Category 1.27% 9.72% 12.60% 47.44% 45.01% 41.86% 38.83% 33.64% 34.22%
Worst in Category -1.19% -5.57% -5.08% -9.73% -20.64% -17.27% 1.61% 6.48% 2.80%

Best Quarters

Period This Fund Nifty 50 Nifty Pharma TRI Category Average
Q3 - 2024 18.06% 6.91% -- 9%
Q3 - 2024 17.91% 6.91% -- 9%
Q2 - 2023 13.70% 10.29% -- 8.99%

Worst Quarters

Period This Fund Nifty 50 Nifty Pharma TRI Category Average
Q1 - 2023 -4.58% -4.60% -- -2.64%
Q1 - 2025 -9.84% -2.43% -- -2.54%
Q1 - 2023 -4.58% -4.60% -- -2.64%
Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347